Ark Therapeutics Group (AKT)

   Trade now with Barclays Stockbrokers   Trade now with Barclays   Sponsored by Barclays Stockbrokers

 0.000p
   
  • Closing Price Chg:
      0.000p
  • 52 Week High: 0.54
  • 52 Week Low: 0.54
  • Currency: UK Pounds
  • Shares Issued: 209.28m
  • Volume: 0
  • RiskGrade: 72

Latest ShareCast News

Ark in dispute with Crawford Healthcare over earn-out payments

Date: Friday 05 Jul 2013

Ark Therapeutics has revealed details of a row with Crawford Healthcare concerning an earn-out payment tied to the sale of its woundcare business in 2011.

Ark Therapeutics primes market for likely financing update

Date: Monday 21 Jan 2013

Viral product-focused manufacturing services company Ark Therapeutics expects to update the market soon regarding possible financing, an announcement issued by the company on Monday disclosed.

JD Wetherspoon founder gets some more in

Date: Friday 18 May 2012

A round-up of the biggest director deals today so far.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

AKT Market Data

Currency UK Pounds
Share Price 0.000p
Closing Price Change 0.000p
% Change 0.00 %
52 Week High 0.54
52 Week Low 0.54
Volume 0
Shares Issued 209.28m
RiskGrade 72

AKT Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value Not Available
Value Not Available
Income Not Available
Growth
23.81% above the market average23.81% above the market average23.81% above the market average23.81% above the market average23.81% above the market average
35.00% above the sector average35.00% above the sector average35.00% above the sector average35.00% above the sector average35.00% above the sector average

AKT Dividends

No dividends found

Trades for --2014

Time Volume / Share Price
0 @ 0.000p

AKT Key Personnel

CEO Martyn Williams
CFO Russell Banks

Top of Page